Emerging aspects of treatment in mitochondrial disorders

[1]  R. Horvath,et al.  Reversible infantile mitochondrial diseases , 2015, Journal of Inherited Metabolic Disease.

[2]  Marcella Attimonelli,et al.  Mitochondrial Disease Sequence Data Resource (MSeqDR): a global grass-roots consortium to facilitate deposition, curation, annotation, and integrated analysis of genomic data for the mitochondrial disease clinical and research communities. , 2015, Molecular genetics and metabolism.

[3]  L. Buydens,et al.  Quantifying small molecule phenotypic effects using mitochondrial morpho-functional fingerprinting and machine learning , 2015, Scientific Reports.

[4]  J. Doudna,et al.  The new frontier of genome engineering with CRISPR-Cas9 , 2014, Science.

[5]  S. Rahman,et al.  Paediatric single mitochondrial DNA deletion disorders: an overlapping spectrum of disease , 2014, Journal of Inherited Metabolic Disease.

[6]  H. Smeets,et al.  Reply: Infantile Leigh-like syndrome caused by SLC19A3 mutations is a treatable disease. , 2014, Brain : a journal of neurology.

[7]  S. Kuo,et al.  Delivering healthy mitochondria for the therapy of mitochondrial diseases and beyond. , 2014, The international journal of biochemistry & cell biology.

[8]  M. Fleming,et al.  Pearson marrow pancreas syndrome in patients suspected to have Diamond-Blackfan anemia. , 2014, Blood.

[9]  E. Schon,et al.  NAD+-Dependent Activation of Sirt1 Corrects the Phenotype in a Mouse Model of Mitochondrial Disease , 2014, Cell metabolism.

[10]  R. Lightowlers,et al.  Salvaging hope: Is increasing NAD+ a key to treating mitochondrial myopathy? , 2014, EMBO molecular medicine.

[11]  M. Nireekshan Kumar,et al.  Miro1 regulates intercellular mitochondrial transport & enhances mesenchymal stem cell rescue efficacy , 2014, The EMBO journal.

[12]  M. Hirano,et al.  Administration of deoxyribonucleosides or inhibition of their catabolism as a pharmacological approach for mitochondrial DNA depletion syndrome. , 2014, Human molecular genetics.

[13]  J. Cross,et al.  The ketogenic diet component decanoic acid increases mitochondrial citrate synthase and complex I activity in neuronal cells , 2014, Journal of neurochemistry.

[14]  M. Tarnopolsky,et al.  Beneficial effects of resveratrol on respiratory chain defects in patients' fibroblasts involve estrogen receptor and estrogen-related receptor alpha signaling. , 2014, Human molecular genetics.

[15]  L. de Meirleir,et al.  A multicenter study on Leigh syndrome: disease course and predictors of survival , 2014, Orphanet Journal of Rare Diseases.

[16]  J. Auwerx,et al.  Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3 , 2014, EMBO molecular medicine.

[17]  H. Jacobs,et al.  Engineering the alternative oxidase gene to better understand and counteract mitochondrial defects: state of the art and perspectives , 2014, British journal of pharmacology.

[18]  S. Rahman,et al.  Development of pharmacological strategies for mitochondrial disorders , 2014, British journal of pharmacology.

[19]  M. Minczuk,et al.  Mitochondrially targeted ZFNs for selective degradation of pathogenic mitochondrial genomes bearing large-scale deletions or point mutations , 2014, EMBO molecular medicine.

[20]  P. Laforêt,et al.  Bezafibrate in skeletal muscle fatty acid oxidation disorders , 2014, Neurology.

[21]  S. Seneca,et al.  Effect of Resveratrol on Cultured Skin Fibroblasts from Patients with Oxidative Phosphorylation Defects , 2014, Phytotherapy research : PTR.

[22]  L. Frontali,et al.  Human mitochondrial leucyl tRNA synthetase can suppress non cognate pathogenic mt-tRNA mutations , 2014, EMBO molecular medicine.

[23]  Robert W. Taylor,et al.  The isolated carboxy-terminal domain of human mitochondrial leucyl-tRNA synthetase rescues the pathological phenotype of mitochondrial tRNA mutations in human cells , 2014, EMBO molecular medicine.

[24]  Matt Kaeberlein,et al.  mTOR Inhibition Alleviates Mitochondrial Disease in a Mouse Model of Leigh Syndrome , 2013, Science.

[25]  S. Züchner,et al.  Treatable childhood neuronopathy caused by mutations in riboflavin transporter RFVT2 , 2013, Brain : a journal of neurology.

[26]  H. Harashima,et al.  Mitochondrial targeting functional peptides as potential devices for the mitochondrial delivery of a DF-MITO-Porter. , 2013, Mitochondrion.

[27]  S. Rahman,et al.  Treatable Leigh-like encephalopathy presenting in adolescence , 2013, BMJ Case Reports.

[28]  P. Tonin,et al.  Clinical/Scientific Notes , 2011, Neurology.

[29]  E. González-Vioque,et al.  Feeding the deoxyribonucleoside salvage pathway to rescue mitochondrial DNA. , 2013, Drug discovery today.

[30]  K. Reinhardt,et al.  Mitochondrial Replacement, Evolution, and the Clinic , 2013, Science.

[31]  C. Moraes,et al.  Specific elimination of mutant mitochondrial genomes in patient–derived cells by mitoTALENs , 2013, Nature Medicine.

[32]  Robert W. Taylor,et al.  SURF1 deficiency: a multi-centre natural history study , 2013, Orphanet Journal of Rare Diseases.

[33]  R. Artuch,et al.  Reversible Lactic Acidosis in a Newborn With Thiamine Transporter-2 Deficiency , 2013, Pediatrics.

[34]  D. Mochly‐Rosen,et al.  A novel Drp1 inhibitor diminishes aberrant mitochondrial fission and neurotoxicity , 2013, Journal of Cell Science.

[35]  D. Kerr.  Review of Clinical Trials for Mitochondrial Disorders: 1997–2012 , 2013, Neurotherapeutics.

[36]  Robert W. Taylor,et al.  The UK MRC Mitochondrial Disease Patient Cohort Study: clinical phenotypes associated with the m.3243A>G mutation—implications for diagnosis and management , 2013, Journal of Neurology, Neurosurgery & Psychiatry.

[37]  I. D. de Coo,et al.  Preimplantation genetic diagnosis in mitochondrial DNA disorders: challenge and success , 2013, Journal of Medical Genetics.

[38]  P. Bénit,et al.  Alternative Oxidase Expression in the Mouse Enables Bypassing Cytochrome c Oxidase Blockade and Limits Mitochondrial ROS Overproduction , 2013, PLoS genetics.

[39]  P. J. Elliot,et al.  A Pilot Randomized, Placebo Controlled, Double Blind Phase I Trial of the Novel SIRT1 Activator SRT2104 in Elderly Volunteers , 2012, PloS one.

[40]  Tao Li,et al.  Adeno‐associated virus‐mediated gene delivery of the human ND4 complex I subunit in rabbit eyes , 2012, Clinical & experimental ophthalmology.

[41]  B. Levy,et al.  Blastocyst preimplantation genetic diagnosis (PGD) of a mitochondrial DNA disorder. , 2012, Fertility and sterility.

[42]  E. Bertini,et al.  EPI-743 reverses the progression of the pediatric mitochondrial disease--genetically defined Leigh Syndrome. , 2012, Molecular genetics and metabolism.

[43]  S. Mitalipov,et al.  Towards germline gene therapy of inherited mitochondrial diseases , 2012, Nature.

[44]  Yau-Huei Wei,et al.  Functional Recovery of Human Cells Harbouring the Mitochondrial DNA Mutation MERRF A8344G via Peptide-Mediated Mitochondrial Delivery , 2012, Neurosignals.

[45]  M. Zeviani,et al.  Effective AAV-mediated gene therapy in a mouse model of ethylmalonic encephalopathy , 2012, EMBO molecular medicine.

[46]  U. Wolfrum,et al.  Intravitreal delivery of AAV-NDI1 provides functional benefit in a murine model of Leber hereditary optic neuropathy , 2012, European Journal of Human Genetics.

[47]  S. Rahman.  Mitochondrial disease and epilepsy , 2012, Developmental medicine and child neurology.

[48]  D. Rowlands,et al.  Mitochondrial transfer from bone-marrow–derived stromal cells to pulmonary alveoli protects against acute lung injury , 2012, Nature Medicine.

[49]  S. Rahman,et al.  Plasma thiol status is altered in children with mitochondrial diseases , 2012, Scandinavian journal of clinical and laboratory investigation.

[50]  P. Barboni,et al.  Effect of EPI-743 on the clinical course of the mitochondrial disease Leber hereditary optic neuropathy. , 2012, Archives of neurology.

[51]  Philip Bradley,et al.  The Crystal Structure of TAL Effector PthXo1 Bound to Its DNA Target , 2012, Science.

[52]  A. Suomalainen,et al.  Effect of bezafibrate treatment on late-onset mitochondrial myopathy in mice. , 2012, Human molecular genetics.

[53]  S. Rahman,et al.  176th ENMC International Workshop: Diagnosis and treatment of coenzyme Q10 deficiency , 2012, Neuromuscular Disorders.

[54]  A. Di Cataldo,et al.  Clinical manifestations and management of four children with Pearson syndrome , 2011, American journal of medical genetics. Part A.

[55]  S. Dimauro,et al.  Natural history of MELAS associated with mitochondrial DNA m.3243A>G genotype , 2011, Neurology.

[56]  D. Green,et al.  SnapShot: Mitochondrial Quality Control , 2011, Cell.

[57]  L. Frontali,et al.  Peptides from aminoacyl-tRNA synthetases can cure the defects due to mutations in mt tRNA genes , 2011, Mitochondrion.

[58]  Anna Golubitzky,et al.  Screening for Active Small Molecules in Mitochondrial Complex I Deficient Patient's Fibroblasts, Reveals AICAR as the Most Beneficial Compound , 2011, PloS one.

[59]  J. Barquinero,et al.  Hematopoietic gene therapy restores thymidine phosphorylase activity in a cell culture and a murine model of MNGIE , 2011, Gene Therapy.

[60]  P. Chinnery,et al.  A randomized placebo-controlled trial of idebenone in Leber’s hereditary optic neuropathy , 2011, Brain : a journal of neurology.

[61]  E. Schon,et al.  In Vivo Correction of COX Deficiency by Activation of the AMPK/PGC-1α Axis , 2011, Cell metabolism.

[62]  H. Mandel,et al.  Allogeneic hematopoietic SCT as treatment option for patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a consensus conference proposal for a standardized approach , 2011, Bone Marrow Transplantation.

[63]  A. Bredenoord,et al.  Ethics of modifying the mitochondrial genome , 2010, Journal of Medical Ethics.

[64]  V. Tiranti,et al.  Combined treatment with oral metronidazole and N-acetylcysteine is effective in ethylmalonic encephalopathy , 2010, Nature Medicine.

[65]  M. Orešič,et al.  Ketogenic diet slows down mitochondrial myopathy progression in mice. , 2010, Human molecular genetics.

[66]  Patrick F Chinnery,et al.  Pronuclear transfer in human embryos to prevent transmission of mitochondrial DNA disease , 2010, Nature.

[67]  W. Hauswirth,et al.  Efficiency and safety of AAV-mediated gene delivery of the human ND4 complex I subunit in the mouse visual system. , 2009, Investigative ophthalmology & visual science.

[68]  S. Rahman,et al.  Diagnosis and therapy in neuromuscular disorders: diagnosis and new treatments in mitochondrial diseases , 2009, Journal of Neurology, Neurosurgery & Psychiatry.

[69]  Y. Li,et al.  Mitochondrial Gene Replacement in Primate Offspring and Embryonic Stem Cells , 2009, Nature.

[70]  H. Jacobs,et al.  Expression of the alternative oxidase complements cytochrome c oxidase deficiency in human cells , 2009, EMBO molecular medicine.

[71]  J. Smeitink,et al.  The antioxidant Trolox restores mitochondrial membrane potential and Ca2+-stimulated ATP production in human complex I deficiency , 2009, Journal of Molecular Medicine.

[72]  S. Rahman,et al.  Diagnosis of mitochondrial DNA depletion syndromes , 2008, Archives of Disease in Childhood.

[73]  Robert W. Taylor,et al.  Resistance training in patients with single, large-scale deletions of mitochondrial DNA. , 2008, Brain : a journal of neurology.

[74]  M. King,et al.  Overexpressed mitochondrial leucyl-tRNA synthetase suppresses the A3243G mutation in the mitochondrial tRNA(Leu(UUR)) gene. , 2008, RNA.

[75]  J. Sahel,et al.  Optimized allotopic expression of the human mitochondrial ND4 prevents blindness in a rat model of mitochondrial dysfunction. , 2008, American journal of human genetics.

[76]  B. Spiegelman,et al.  Activation of the PPAR/PGC-1alpha pathway prevents a bioenergetic deficit and effectively improves a mitochondrial myopathy phenotype. , 2008, Cell metabolism.

[77]  M. Muqit,et al.  CARRIER ERYTHROCYTE ENTRAPPED THYMIDINE PHOSPHORYLASE THERAPY FOR MNGIE , 2008, Neurology.

[78]  L. Salviati,et al.  Early coenzyme Q10 supplementation in primary coenzyme Q10 deficiency. , 2008, The New England journal of medicine.

[79]  Aaron Klug,et al.  Development of a single-chain, quasi-dimeric zinc-finger nuclease for the selective degradation of mutated human mitochondrial DNA , 2008, Nucleic acids research.

[80]  I. Hargreaves,et al.  ALLOGENEIC STEM CELL TRANSPLANTATION CORRECTS BIOCHEMICAL DERANGEMENTS IN MNGIE , 2007, Neurology.

[81]  Robert W. Taylor,et al.  Endurance training and detraining in mitochondrial myopathies due to single large-scale mtDNA deletions. , 2006, Brain : a journal of neurology.

[82]  H. Jacobs,et al.  Allotopic expression of a mitochondrial alternative oxidase confers cyanide resistance to human cell respiration , 2006, EMBO reports.

[83]  Darwin J. Prockop,et al.  Mitochondrial transfer between cells can rescue aerobic respiration , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[84]  R. Haller,et al.  Exercise and training in mitochondrial myopathies. , 2005, Medicine and science in sports and exercise.

[85]  M. Duchen,et al.  Induction of mitochondrial oxidative stress in astrocytes by nitric oxide precedes disruption of energy metabolism , 2005, Journal of neurochemistry.

[86]  S. Heales,et al.  Glutathione deficiency in patients with mitochondrial disease: Implications for pathogenesis and treatment , 2005, Journal of Inherited Metabolic Disease.

[87]  E. Schon,et al.  Ketogenic treatment reduces deleted mitochondrial DNAs in cultured human cells , 2004, Annals of neurology.

[88]  D. Thorburn,et al.  Mitochondrial disorders: Prevalence, myths and advances , 2004, Journal of Inherited Metabolic Disease.

[89]  E. Schon,et al.  Rescue of a deficiency in ATP synthesis by transfer of MTATP6, a mitochondrial DNA-encoded gene, to the nucleus , 2002, Nature Genetics.

[90]  M. Bolotin-Fukuhara,et al.  Additional copies of the mitochondrial Ef-Tu and aspartyl-tRNA synthetase genes can compensate for a mutation affecting the maturation of the mitochondrial tRNAAsp , 1997, Current Genetics.

[91]  T. Meitinger,et al.  Infantile Leigh-like syndrome caused by SLC19A3 mutations is a treatable disease. , 2014, Brain : a journal of neurology.

[92]  S. Mitalipov,et al.  Three-parent in vitro fertilization: gene replacement for the prevention of inherited mitochondrial diseases. , 2014, Fertility and sterility.

[93]  Robert W. Taylor,et al.  Isoleucyl-tRNA synthetase levels modulate the penetrance of a homoplasmic m.4277T>C mitochondrial tRNA(Ile) mutation causing hypertrophic cardiomyopathy. , 2012, Human molecular genetics.

[94]  F. Blankenberg,et al.  Initial experience in the treatment of inherited mitochondrial disease with EPI-743. , 2012, Molecular genetics and metabolism.

[95]  H. Smeets,et al.  Riboflavin-responsive oxidative phosphorylation complex I deficiency caused by defective ACAD9: new function for an old gene. , 2011, Brain : a journal of neurology.

[96]  D. Turnbull,et al.  Treatment for mitochondrial disorders. , 2006, The Cochrane database of systematic reviews.

[97]  Y. Akao,et al.  Gene therapy for mitochondrial disease by delivering restriction endonuclease SmaI into mitochondria. , 2002, Journal of biomedical science.